Thomas J. van Rijssen

1.1k total citations · 1 hit paper
23 papers, 768 citations indexed

About

Thomas J. van Rijssen is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Thomas J. van Rijssen has authored 23 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Ophthalmology, 10 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Epidemiology. Recurrent topics in Thomas J. van Rijssen's work include Retinal Diseases and Treatments (23 papers), Retinal and Optic Conditions (13 papers) and Glaucoma and retinal disorders (12 papers). Thomas J. van Rijssen is often cited by papers focused on Retinal Diseases and Treatments (23 papers), Retinal and Optic Conditions (13 papers) and Glaucoma and retinal disorders (12 papers). Thomas J. van Rijssen collaborates with scholars based in Netherlands, Switzerland and Germany. Thomas J. van Rijssen's co-authors include Camiel J. F. Boon, Elon H. C. van Dijk, Carel B. Hoyng, Sascha Fauser, Susan M. Downes, Suzanne Yzer, Greet Dijkman, Reinier O. Schlingemann, Jan E.E. Keunen and Giuseppe Querques and has published in prestigious journals such as PLoS ONE, Scientific Reports and American Journal of Ophthalmology.

In The Last Decade

Thomas J. van Rijssen

23 papers receiving 745 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Central serous chorioretinopathy: Towards an evidence-based treatment guideline

2019 314 citations Thomas J. van Rijssen, Elon H. C. van Dijk et al. Progress in Retinal and Eye Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas J. van Rijssen Netherlands	13	728	412	76	65	28	23	768
Paula Scholz Germany	14	565 0.8×	346 0.8×	94 1.2×	50 0.8×	28 1.0×	34	649
Godfrey Quin Australia	7	715 1.0×	489 1.2×	76 1.0×	24 0.4×	14 0.5×	10	754
David A. Salz United States	9	671 0.9×	568 1.4×	34 0.4×	18 0.3×	74 2.6×	12	719
Luca Ventre Italy	10	658 0.9×	386 0.9×	86 1.1×	30 0.5×	45 1.6×	22	728
Katja Hatz Switzerland	12	563 0.8×	428 1.0×	76 1.0×	32 0.5×	8 0.3×	40	617
Lorna B. Young United Kingdom	11	499 0.7×	333 0.8×	70 0.9×	32 0.5×	27 1.0×	16	524
Luigi Borgia Italy	7	446 0.6×	236 0.6×	53 0.7×	13 0.2×	24 0.9×	14	549
Henrietta Ho Singapore	10	332 0.5×	294 0.7×	17 0.2×	43 0.7×	29 1.0×	23	393
Diana Anna Dmuchowska Poland	12	306 0.4×	177 0.4×	74 1.0×	31 0.5×	8 0.3×	43	400
Bernd A. Kamppeter Germany	16	837 1.1×	563 1.4×	51 0.7×	52 0.8×	24 0.9×	38	864

Countries citing papers authored by Thomas J. van Rijssen

Since Specialization

Citations

This map shows the geographic impact of Thomas J. van Rijssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. van Rijssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. van Rijssen more than expected).

Fields of papers citing papers by Thomas J. van Rijssen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. van Rijssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. van Rijssen. The network helps show where Thomas J. van Rijssen may publish in the future.

Co-authorship network of co-authors of Thomas J. van Rijssen

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. van Rijssen. A scholar is included among the top collaborators of Thomas J. van Rijssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. van Rijssen. Thomas J. van Rijssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dijk, Elon H. C. van, Thomas J. van Rijssen, Roula Tsonaka, et al.. (2022). Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients. Ophthalmology Retina. 6(10). 930–938. 11 indexed citations

Dijk, Elon H. C. van, Thomas J. van Rijssen, Roula Tsonaka, et al.. (2022). Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3. Graefe s Archive for Clinical and Experimental Ophthalmology. 261(3). 659–668. 8 indexed citations

Rijssen, Thomas J. van, Elon H. C. van Dijk, Paula Scholz, et al.. (2021). Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser. Acta Ophthalmologica. 99(7). 805–811. 22 indexed citations

Rijssen, Thomas J. van, Elon H. C. van Dijk, Roula Tsonaka, et al.. (2021). Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial. American Journal of Ophthalmology. 233. 101–110. 60 indexed citations

Haalen, Femke M. van, Thomas J. van Rijssen, Nienke R. Biermasz, et al.. (2021). Central serous chorioretinopathy in active endogenous Cushing’s syndrome. Scientific Reports. 11(1). 2748–2748. 12 indexed citations

Pfau, Maximilian, Elon H. C. van Dijk, Thomas J. van Rijssen, et al.. (2021). Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence. Scientific Reports. 11(1). 20446–20446. 11 indexed citations

Rijssen, Thomas J. van, Elon H. C. van Dijk, Roula Tsonaka, et al.. (2021). RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina. 41(10). 2122–2131. 10 indexed citations

Rijssen, Thomas J. van, Elon H. C. van Dijk, Paula Scholz, et al.. (2020). Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial. American Journal of Ophthalmology. 216. 80–89. 32 indexed citations

Rijssen, Thomas J. van, Sumit Randhir Singh, Elon H. C. van Dijk, et al.. (2020). Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy. Graefe s Archive for Clinical and Experimental Ophthalmology. 258(6). 1191–1197. 22 indexed citations

10.

Rijssen, Thomas J. van, Elon H. C. van Dijk, Paula Scholz, et al.. (2020). Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy. Graefe s Archive for Clinical and Experimental Ophthalmology. 259(4). 905–910. 8 indexed citations

11.

Dijk, Elon H. C. van, Thomas J. van Rijssen, Yousif Subhi, & Camiel J. F. Boon. (2020). Photodynamic Therapy for Chorioretinal Diseases: A Practical Approach. Ophthalmology and Therapy. 9(2). 329–342. 44 indexed citations

12.

Rijssen, Thomas J. van, Paula Scholz, Myrte B. Breukink, et al.. (2019). Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser.. American Journal of Ophthalmology. 6 indexed citations

13.

Rijssen, Thomas J. van, Paula Scholz, Myrte B. Breukink, et al.. (2019). Changes on multimodal imaging after treatment with photodynamic therapy or high-density subthreshold micropulse laser in chronic central serous chorioretinopathy. 60(9). 1155–1155. 1 indexed citations

14.

Rijssen, Thomas J. van, Elon H. C. van Dijk, Paula Scholz, et al.. (2019). Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3. American Journal of Ophthalmology. 205. 1–10. 44 indexed citations

15.

Rijssen, Thomas J. van, Elon H. C. van Dijk, Suzanne Yzer, et al.. (2019). Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Progress in Retinal and Eye Research. 73. 100770–100770. 314 indexed citations breakdown →

16.

Rijssen, Thomas J. van, Elon H. C. van Dijk, Paula Scholz, et al.. (2019). Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage. Graefe s Archive for Clinical and Experimental Ophthalmology. 257(7). 1419–1425. 15 indexed citations

17.

Rijssen, Thomas J. van, Greet Dijkman, Thomas Theelen, et al.. (2018). Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy. PLoS ONE. 13(8). e0202549–e0202549. 29 indexed citations

18.

Dijk, Elon H. C. van, Thomas J. van Rijssen, Eiko K. de Jong, et al.. (2018). Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy. Clinical ophthalmology. Volume 12. 2167–2176. 31 indexed citations

19.

Rijssen, Thomas J. van, Gregorius P. M. Luyten, Tom Missotten, et al.. (2018). Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy. Clinical ophthalmology. Volume 12. 1061–1070. 48 indexed citations

20.

Rijssen, Thomas J. van, Elon H. C. van Dijk, Greet Dijkman, & Camiel J. F. Boon. (2018). Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy. Graefe s Archive for Clinical and Experimental Ophthalmology. 256(8). 1395–1402. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact